How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?

dc.contributor.advisor	Buetow, S	en
dc.contributor.advisor	Kelly, F	en
dc.contributor.advisor	Bryant, L	en
dc.contributor.advisor	Jessamine, S	en
dc.contributor.advisor	Emmerton, L	en
dc.contributor.author	Gauld, Natalie	en
dc.date.accessioned	2014-03-03T21:57:09Z	en
dc.date.issued	2013	en
dc.identifier.uri	http://hdl.handle.net/2292/21782	en
dc.publisher	ResearchSpace@Auckland	en
dc.relation.ispartof	PhD Thesis - University of Auckland	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.title	How and why do developed countries vary in reclassifying medicines from prescription to non-prescription?	en
dc.type	Thesis	en
thesis.degree.grantor	The University of Auckland	en
thesis.degree.level	Doctoral	en
thesis.degree.name	PhD	en
dc.rights.holder	Copyright: The Author	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/OpenAccess	en
pubs.elements-id	429705	en
pubs.record-created-at-source-date	2014-03-04	en
dc.identifier.wikidata	Q112200772

Files in this item

Name: whole.pdf

Size: 4.225Mb

Format: PDF